Malignant News and Research

RSS

New ULB study shows how cancer cell of origin controls malignant transition

Researchers at the Université libre de Bruxelles, ULB define for the first time how the cancer cell of origin controls invasive and metastatic properties of tumor cells.

24 Nov 2016

New study describes role of protein that is crucial for melanoma cell survival

The main goals of the Melanoma Group at the Spanish National Cancer Research Centre are to identify biomarkers of tumour progression and to validate novel therapeutic targets in melanoma.

21 Nov 2016

Johns Hopkins researchers develop new, highly accurate urine test to predict risk for cervical cancer

Johns Hopkins Medicine specialists report they have developed a urine test for the likely emergence of cervical cancer that is highly accurate compared to other tests based on genetic markers derived directly from cervical tissue.

17 Nov 2016

Sleep apnea can make lung cancer more dangerous by increasing tumor growth

A team of researchers from the University of Chicago and the University of Barcelona has found that intermittent hypoxia, or an irregular lack of air experienced by people with sleep apnea, can increase tumor growth by promoting the release of circulating exosomes.

17 Nov 2016

Tumour cell of origin in childhood malignant glioma impacts susceptibility to cancer therapy

Children that are diagnosed with the severe the brain tumour malignant glioma often have a very poor prognosis. Knowledge about how pediatric malignant glioma arises and develops is still limited.

17 Nov 2016

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan plc, a leading global pharmaceutical company, today announced the availability of TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1mg/20mcg, the first and only oral contraceptive in a softgel capsule for the prevention of pregnancy

10 Nov 2016

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

SMU virologist and cancer researcher Robert L. Harrod has been awarded a $436,500 grant from the National Cancer Institute to further his lab's research into how certain viruses cause cancers in humans.

8 Nov 2016

Researchers discover signaling pathway that can stop brain tumor formation in animal models

A research team at the Krembil Research Institute has discovered that a signaling pathway which controls blood vessel development in the brain has the ability to stop brain tumor formation in animal models of medulloblastoma, the most common malignant brain tumor diagnosed in children.

8 Nov 2016

New treatment with therapeutic short interfering RNA could help thwart cancer

In the fight against cancer, doctors dish out combination-blows of surgery, chemotherapy and other drugs to beat back a merciless foe. Now, scientists have taken early steps toward adding a stinging punch to clinicians' repertoire.

7 Nov 2016

Gut microbiome may help improve immunotherapy response in melanoma patients

Patients with malignant melanoma - whose disease has spread - are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool.

6 Nov 2016

Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Combination therapy utilizing two approved immunotherapy drugs for cancer treatment may cause rare and sometimes fatal cardiac side effects linked to an unexpected immune response.

4 Nov 2016

Study shows promise for successful ovarian transplantation in future

Approximately 11% of women worldwide suffer from premature ovarian failure. This can have many different causes: chemotherapy administered for a malignant disease might irreversibly damage the ovaries and, because of the advances in modern cancer therapy, the number of young women surviving cancer is on the increase.

2 Nov 2016

Malignant News and Research

New ULB study shows how cancer cell of origin controls malignant transition

New study describes role of protein that is crucial for melanoma cell survival

Johns Hopkins researchers develop new, highly accurate urine test to predict risk for cervical cancer

Sleep apnea can make lung cancer more dangerous by increasing tumor growth

Tumour cell of origin in childhood malignant glioma impacts susceptibility to cancer therapy

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

Researchers discover signaling pathway that can stop brain tumor formation in animal models

New treatment with therapeutic short interfering RNA could help thwart cancer

Gut microbiome may help improve immunotherapy response in melanoma patients

Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Study shows promise for successful ovarian transplantation in future

Researchers identify potential new treatment for brain cancer by targeting genes linked to microcephaly

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Myriad Genetics presents research data that validates accuracy of myPath Melanoma test

Fission yeast could help discover novel cancer drugs

Researchers develop new, highly-specific functional imaging probe to detect hypoxic tumors

Scientists discover new option for treating malignant pleural mesothelioma

Yale researchers develop new mouse model to understand multiple myeloma

Natural compound isolated from onions contains anti-ovarian cancer properties, research finds

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News